De Letter Els A, Piette Michel H A, Lambert Willy E, Cordonnier Jan A C M
Ghent University, Department of Forensic Medicine, Belgium.
Med Sci Law. 2006 Jan;46(1):37-65. doi: 10.1258/rsmmsl.46.1.37.
Abuse of amphetamine (AMP) and its derivatives, such as 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), 3,4-methylenedioxyethylamphetamine (MDEA, MDE), and 3,4-methylenedioxyamphetamine (MDA) is an important public issue. Fatalities following ingestion of these substances are not infrequent in current forensic practice. The aim of this study was twofold. Firstly, considering the wide range of blood levels reported in fatalities, to provide insight into the interpretation of a quantified blood level and, secondly, to examine and discuss possible causes, mechanisms and manners of death. All the medico-legal files between January 1976 and December 2004 were skimmed through to investigate whether amphetamine and/or derivatives were involved in the fatal outcome. Particularly, in addition to overdose cases due to or including amphetamines, all amphetamines-related fatalities were examined. In addition to AMP, MDMA, MDEA, and MDA, two other amphetamine derivatives, namely 4-methylthioamphetamine (4-MTA) and para-methoxyamphetamine (PMA) were considered. In 34 fatalities, amphetamines were involved and the majority were men, under the age of 25 years. A wide range of blood levels was found: e.g. MDMA blood concentrations in cases of 'pure' intoxication were found between 0.27 and 13.51 microg/ml. The age and sex distribution as well as the broad range of quantified amphetamines blood levels were in line with those reported in the literature. In our study group, 'pure' intoxications with amphetamines, polydrug overdoses, and the combination of amphetamines use and polytrauma were the most prominent causes of death. Considering the manner of death in these fatalities, unintentional overdoses were most frequent, though suicides, traffic accidents, and criminal offences associated with amphetamines use also accounted for significant percentages. Acute to subacute cardiopulmonary failure was the most frequent mechanism of death, followed by (poly)trauma, mechanical asphyxia, and hyperthermia, respectively. In conclusion, although amphetamines-related fatalities are only a fraction of the total number of fatalities studied at our Department, their contribution to current forensic practice has been increasing during the last few years. As there is still considerable debate as to what level of amphetamines can be toxic or even potentially lethal, it is strongly advisable to interpret the anatomo-pathological findings and the toxicological results together in arriving at a conclusion. This guideline is important in view of the different possible mechanisms of death which implicate quite different survival times following intake of amphetamine and/or its derivatives (e.g. cardiopulmonary complications, hyperthermia).
滥用苯丙胺(AMP)及其衍生物,如3,4-亚甲基二氧基甲基苯丙胺(MDMA,“摇头丸”)、3,4-亚甲基二氧基乙基苯丙胺(MDEA,MDE)和3,4-亚甲基二氧基苯丙胺(MDA)是一个重要的公共问题。在当前的法医实践中,摄入这些物质后导致死亡的情况并不罕见。本研究的目的有两个。首先,考虑到死亡案例中报告的血液浓度范围很广,深入了解定量血液浓度的解读;其次,研究并讨论可能的死亡原因、机制和方式。查阅了1976年1月至2004年12月期间所有的法医档案,以调查苯丙胺和/或其衍生物是否与死亡结果有关。特别是,除了因苯丙胺或包含苯丙胺导致的过量用药案例外,所有与苯丙胺相关的死亡案例都进行了检查。除了AMP、MDMA、MDEA和MDA外,还考虑了另外两种苯丙胺衍生物,即4-甲硫基苯丙胺(4-MTA)和对甲氧基苯丙胺(PMA)。在34例死亡案例中,涉及了苯丙胺,其中大多数是25岁以下的男性。发现了广泛的血液浓度范围:例如,在“单纯”中毒案例中,MDMA血液浓度在0.27至13.51微克/毫升之间。年龄和性别分布以及苯丙胺定量血液浓度的广泛范围与文献报道一致。在我们的研究组中,苯丙胺“单纯”中毒、多种药物过量以及苯丙胺使用与多发伤的组合是最主要的死亡原因。考虑到这些死亡案例的死亡方式,意外过量用药最为常见,不过与苯丙胺使用相关的自杀、交通事故和刑事犯罪也占了相当比例。急性至亚急性心肺衰竭是最常见的死亡机制,其次分别是(多)创伤性、机械性窒息和体温过高。总之,尽管与苯丙胺相关的死亡案例仅占我们部门研究的死亡案例总数的一小部分,但在过去几年中,它们对当前法医实践的贡献一直在增加。由于对于何种水平的苯丙胺会有毒甚至可能致命仍存在相当大的争议,强烈建议在得出结论时将解剖病理学发现和毒理学结果结合起来解读。鉴于摄入苯丙胺和/或其衍生物后不同的可能死亡机制(如心肺并发症和体温过高)涉及不同的存活时间,这一指导原则很重要。